Orion Oyj

Major Shareholding Notification • Nov 28, 2019

Disclosure 377040

Orion - Major shareholder announcements

Orion Corporation: Disclosure under chapter 9, section 10 of the Securities Market Act: The total share of voting rights of Orion shares owned by Maa- ja vesitekniikan tuki ry and a company controlled by it, Tukinvest Oy, has exceeded 5%

ORION CORPORATION STOCK EXCHANGE RELEASE 28 NOVEMBER 2019 at 10.20 EET

Orion Corporation: Disclosure under chapter 9, section 10 of the Securities Market Act: The total share of voting rights of Orion shares owned by Maa- ja vesitekniikan tuki ry and a company controlled by it, Tukinvest Oy, has exceeded 5%

Orion Corporation has on 28 November 2019 received from Maa- ja vesitekniikan tuki ry a notification under Chapter 9, Section 5 of the Securities Markets Act, according to which the total share of voting rights of the Orion shares owned by Maa- ja vesitekniikan tuki ry and a company controlled by it, Tukinvest Oy, has exceeded 5% in consequence of the share conversion under the Articles of Association of Orion Corporation executed on 28 November 2019.

According to the notification, the total share of voting rights of Maa- ja vesitekniikan tuki ry and Tukinvest Oy is 5.01%.

Total positions of Maa- ja vesitekniikan tuki ry and Tukinvest Oy:

	% of voting rights (a)	% of votes through financial instruments (b)	Total of both in % (a+b)	Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed or reached	5.01%	-	5.01%	832,276,561
Position of previous notification (if applicable)	-	-	-	-
	% of shares (a)	% of shares through financial instruments (b)	Total of both in % (a+b)	Total number of shares of issuer
Resulting situation on the date on which threshold was crossed or reached	1.47%	-	1.47%	141,257,828
Position of previous notification (if applicable)	-	-	-	-

Notified details of the resulting situation on the date on which the threshold was crossed or reached::

Class/type of shares ISIN code	Number of voting rights	% of voting rights
	Direct (SMA 9:5)	Indirect (SMA 9:6 and 9:7)	Direct (SMA 9:5)	Indirect (SMA 9:6 and 9:7)
A share, FI0009014369	20,697,200	20,970,000	2.49%	2.52%
B share, FI0009014377	-	-	-	-
TOTAL	41,667,200	5.01%
Class/type of shares ISIN code	Number of shares	% of shares
	Direct (SMA 9:5)	Indirect (SMA 9:6 and 9:7)	Direct (SMA 9:5)	Indirect (SMA 9:6 and 9:7)
A share, FI0009014369	1,034,860	1,048,500	0.73%	0.74%
B share, FI0009014377	-	-	-	-
TOTAL	2,083,360	1.47%

Information in relation to person subject to the notification obligation:

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights	% of voting rights through financial instruments	Total of both
Maa- ja vesitekniikan tuki ry	2.49%	-	2.49%
Tukinvest Oy	2.52%	-	2.52%
Name	% of shares	% of shares through financial instruments	Total of both
Maa- ja vesitekniikan tuki ry	0.73%	-	0.73%
Tukinvest Oy	0.74%	-	0.74%

Orion Corporation

Jari Karlson CFO		Olli Huotari SVP, Corporate Functions

Contact person:

Tuukka Hirvonen, Investor Relations, tel. +358 010 426 2721

Publisher:

Orion Corporation

Communications

Orionintie 1A, FI-02200 Espoo, Finland

www.orion.fi

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion’s pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs. Orion’s net sales in 2018 amounted to EUR 977 million and the company had about 3,200 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.